Advertisement

Topics

Ra Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference

07:00 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Ra Pharmaceuticals, Inc., (NASDAQ:RARX), a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, today announced that Doug Treco, ...

Other Sources for this Article

Ra Pharmaceuticals, Inc.
Investors:
Jennifer Robinson, 617.674.9873
jrobinson@rapharma.com
or
Media:
Argot Partners
Eliza Schleifstein, 917.763.8106
eliza@argotpartners.com

NEXT ARTICLE

More From BioPortfolio on "Ra Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...